JP2016535065A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016535065A5 JP2016535065A5 JP2016540347A JP2016540347A JP2016535065A5 JP 2016535065 A5 JP2016535065 A5 JP 2016535065A5 JP 2016540347 A JP2016540347 A JP 2016540347A JP 2016540347 A JP2016540347 A JP 2016540347A JP 2016535065 A5 JP2016535065 A5 JP 2016535065A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine composition
- sucrose
- trehalose
- maltodextrin
- sorbitol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 73
- 229960005486 vaccine Drugs 0.000 claims 44
- 239000000546 pharmaceutical excipient Substances 0.000 claims 24
- 239000000427 antigen Substances 0.000 claims 23
- 102000036639 antigens Human genes 0.000 claims 23
- 108091007433 antigens Proteins 0.000 claims 23
- 229930006000 Sucrose Natural products 0.000 claims 21
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 21
- 239000005720 sucrose Substances 0.000 claims 21
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 20
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims 19
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims 19
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims 19
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 16
- 239000005913 Maltodextrin Substances 0.000 claims 16
- 229920002774 Maltodextrin Polymers 0.000 claims 16
- 229940035034 maltodextrin Drugs 0.000 claims 16
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 15
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 15
- 239000000600 sorbitol Substances 0.000 claims 15
- 206010022000 influenza Diseases 0.000 claims 14
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 12
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 12
- 239000004473 Threonine Substances 0.000 claims 12
- 239000004475 Arginine Substances 0.000 claims 11
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 11
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 11
- 238000000034 method Methods 0.000 claims 11
- 201000005505 Measles Diseases 0.000 claims 10
- 229960003080 taurine Drugs 0.000 claims 10
- 238000009472 formulation Methods 0.000 claims 9
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 8
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims 8
- 239000004471 Glycine Substances 0.000 claims 8
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims 8
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 8
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 8
- 229960001230 asparagine Drugs 0.000 claims 8
- 235000009582 asparagine Nutrition 0.000 claims 8
- KZSFSNALALMADB-XUEOBZAXSA-L calcium (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O KZSFSNALALMADB-XUEOBZAXSA-L 0.000 claims 8
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 8
- 239000007787 solid Substances 0.000 claims 8
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims 6
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims 6
- 239000007864 aqueous solution Substances 0.000 claims 6
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims 6
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 claims 6
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims 6
- 239000000243 solution Substances 0.000 claims 6
- 229940024606 amino acid Drugs 0.000 claims 5
- 235000001014 amino acid Nutrition 0.000 claims 5
- 150000001413 amino acids Chemical class 0.000 claims 5
- 150000001720 carbohydrates Chemical class 0.000 claims 5
- 235000014633 carbohydrates Nutrition 0.000 claims 5
- 238000001035 drying Methods 0.000 claims 5
- 239000001509 sodium citrate Substances 0.000 claims 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 5
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 4
- 230000000052 comparative effect Effects 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 4
- 239000000758 substrate Substances 0.000 claims 4
- 229960004793 sucrose Drugs 0.000 claims 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- 241000712461 unidentified influenza virus Species 0.000 claims 3
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 claims 2
- 229930091371 Fructose Natural products 0.000 claims 2
- 239000005715 Fructose Substances 0.000 claims 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 2
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 claims 2
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims 2
- 239000007983 Tris buffer Substances 0.000 claims 2
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 claims 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims 2
- 239000011248 coating agent Substances 0.000 claims 2
- 238000000576 coating method Methods 0.000 claims 2
- 229960002897 heparin Drugs 0.000 claims 2
- 229920000669 heparin Polymers 0.000 claims 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims 2
- 229960000367 inositol Drugs 0.000 claims 2
- 239000008101 lactose Substances 0.000 claims 2
- 239000004224 potassium gluconate Substances 0.000 claims 2
- 229960003189 potassium gluconate Drugs 0.000 claims 2
- 235000013926 potassium gluconate Nutrition 0.000 claims 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims 2
- HEBKCHPVOIAQTA-ZXFHETKHSA-N ribitol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)CO HEBKCHPVOIAQTA-ZXFHETKHSA-N 0.000 claims 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 claims 2
- 235000019345 sodium thiosulphate Nutrition 0.000 claims 2
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 claims 2
- 229940074410 trehalose Drugs 0.000 claims 2
- 239000000811 xylitol Substances 0.000 claims 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims 2
- 229960002675 xylitol Drugs 0.000 claims 2
- 235000010447 xylitol Nutrition 0.000 claims 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- -1 asperidine Chemical compound 0.000 claims 1
- 208000037797 influenza A Diseases 0.000 claims 1
- 208000037798 influenza B Diseases 0.000 claims 1
- 208000037799 influenza C Diseases 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019082137A JP7358068B2 (ja) | 2013-09-03 | 2019-04-23 | 熱安定性ワクチン製剤及びマイクロニードル |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361873032P | 2013-09-03 | 2013-09-03 | |
| US61/873,032 | 2013-09-03 | ||
| US201361873419P | 2013-09-04 | 2013-09-04 | |
| US61/873,419 | 2013-09-04 | ||
| PCT/US2014/053902 WO2015034924A1 (en) | 2013-09-03 | 2014-09-03 | Thermally stable vaccine formulations and microneedles |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019082137A Division JP7358068B2 (ja) | 2013-09-03 | 2019-04-23 | 熱安定性ワクチン製剤及びマイクロニードル |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016535065A JP2016535065A (ja) | 2016-11-10 |
| JP2016535065A5 true JP2016535065A5 (cg-RX-API-DMAC7.html) | 2017-10-12 |
| JP6611720B2 JP6611720B2 (ja) | 2019-11-27 |
Family
ID=52628897
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016540347A Active JP6611720B2 (ja) | 2013-09-03 | 2014-09-03 | 熱安定性ワクチン製剤及びマイクロニードル |
| JP2019082137A Active JP7358068B2 (ja) | 2013-09-03 | 2019-04-23 | 熱安定性ワクチン製剤及びマイクロニードル |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019082137A Active JP7358068B2 (ja) | 2013-09-03 | 2019-04-23 | 熱安定性ワクチン製剤及びマイクロニードル |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US10736840B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3041504B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6611720B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN105579059B (cg-RX-API-DMAC7.html) |
| CA (1) | CA2923010C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2897659T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2720808C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2015034924A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0402131D0 (en) | 2004-01-30 | 2004-03-03 | Isis Innovation | Delivery method |
| WO2013053022A1 (en) | 2011-10-12 | 2013-04-18 | The University Of Queensland | Delivery device |
| EP3134385A1 (en) | 2014-04-25 | 2017-03-01 | Ajinomoto Co., Inc. | Immunostimulating agent |
| CA2975275C (en) | 2015-02-02 | 2023-08-29 | Vaxxas Pty Limited | Microprojection array applicator and method |
| US20160296149A1 (en) * | 2015-04-08 | 2016-10-13 | Sandia Corporation | In Vivo Extraction of Interstitial Fluid Using Hollow Microneedles |
| CN104984357B (zh) * | 2015-06-02 | 2018-01-30 | 长春百克生物科技股份公司 | 不含明胶的疫苗保护剂组合物及流感减毒活疫苗 |
| US11103259B2 (en) | 2015-09-18 | 2021-08-31 | Vaxxas Pty Limited | Microprojection arrays with microprojections having large surface area profiles |
| CA2999538A1 (en) | 2015-09-28 | 2017-04-06 | Vaxxas Pty Limited | Microprojection arrays with enhanced skin penetrating properties and methods thereof |
| WO2017060329A1 (en) * | 2015-10-06 | 2017-04-13 | Janssen Vaccines & Prevention B.V. | Methods for preventing plastic-induced degradation of biologicals |
| EP3368508A1 (en) | 2015-10-28 | 2018-09-05 | Ajinomoto Co., Inc. | Immunostimulating agent |
| TW201720426A (zh) * | 2015-11-27 | 2017-06-16 | Nitto Denko Corp | 流感疫苗乾燥製劑、及流感疫苗乾燥製劑之製造方法 |
| TW201722478A (zh) * | 2015-11-27 | 2017-07-01 | Nitto Denko Corp | 流感疫苗乾燥製劑、及流感疫苗乾燥製劑之製造方法 |
| CN108289948A (zh) * | 2015-11-27 | 2018-07-17 | 日东电工株式会社 | 口腔内给药用疫苗药物组合物和口腔内给药用疫苗药物组合物的制造方法 |
| US10022436B2 (en) | 2016-01-11 | 2018-07-17 | Verndari, Inc. | Microneedle compositions and methods of using same |
| EP3423040B1 (en) * | 2016-03-01 | 2022-11-09 | Georgia Tech Research Corporation | Microneedle particles and compositions for delivering a substance of interest |
| EP3606760B1 (en) | 2017-03-31 | 2023-09-27 | Vaxxas Pty Limited | Device and method for coating surfaces |
| US11175128B2 (en) | 2017-06-13 | 2021-11-16 | Vaxxas Pty Limited | Quality control of substrate coatings |
| AU2018309562A1 (en) | 2017-08-04 | 2020-02-20 | Vaxxas Pty Limited | Compact high mechanical energy storage and low trigger force actuator for the delivery of microprojection array patches (MAP) |
| CA3072369A1 (en) * | 2017-08-10 | 2019-02-14 | Vaxxas Pty Limited | Differential coating of microprojections and microneedles on arrays |
| CN110870913A (zh) * | 2018-08-31 | 2020-03-10 | 成都夸常奥普医疗科技有限公司 | 氨基酸类营养素作为疫苗佐剂的应用以及包含氨基酸营养素作为佐剂的疫苗 |
| AU2020222113A1 (en) * | 2019-02-15 | 2021-10-07 | Serum Institute Of India Pvt Ltd. | Live attenuated influenza vaccine composition and process for preparation thereof |
| EP3949981A4 (en) * | 2019-03-28 | 2022-05-18 | FUJIFILM Corporation | Microneedle array containing influenza vaccine and method for producing microneedle array |
| CN113874067A (zh) * | 2019-03-29 | 2021-12-31 | 瓦克萨斯私人有限公司 | 用于疫苗的高密度微突出物阵列贴片 |
| IL293214A (en) * | 2019-11-22 | 2022-07-01 | Veradermics Incorporated | Microneedle patch for immunostimulatory drug delivery |
| CN111154833B (zh) * | 2020-01-03 | 2022-08-23 | 浙江夸克生物科技有限公司 | 一种α-L-岩藻糖苷酶测定试剂盒 |
| WO2021252962A1 (en) * | 2020-06-11 | 2021-12-16 | Aquavit Pharmaceuticals, Inc, | Methods and compositions for delivering bioactive compositions to ocular tissue using microneedle devices |
| IL307205A (en) * | 2021-03-23 | 2023-11-01 | Veradermics Incorporated | Perilesional treatment of skin conditions |
| KR20240111761A (ko) * | 2021-11-25 | 2024-07-17 | 오렉쏘 에이비 | 생체의약품 화합물을 포함하는 약학적 조성물 |
| TW202508635A (zh) * | 2023-07-07 | 2025-03-01 | 日商長瀨微態生物科技股份有限公司 | 蛋白質之變性抑制用組成物 |
| US20250325286A1 (en) | 2024-04-17 | 2025-10-23 | Micron Biomedical, Inc. | Methods and Microneedle Devices for Vaccinations with Enhanced Delivery and Acceptance |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6503231B1 (en) | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
| JP2002517300A (ja) | 1998-06-10 | 2002-06-18 | ジョージア テック リサーチ コーポレイション | 微小針デバイスおよび製造方法ならびにそれらの使用 |
| US6743211B1 (en) | 1999-11-23 | 2004-06-01 | Georgia Tech Research Corporation | Devices and methods for enhanced microneedle penetration of biological barriers |
| US6623457B1 (en) | 1999-09-22 | 2003-09-23 | Becton, Dickinson And Company | Method and apparatus for the transdermal administration of a substance |
| WO2002064193A2 (en) | 2000-12-14 | 2002-08-22 | Georgia Tech Research Corporation | Microneedle devices and production thereof |
| US6887484B2 (en) * | 2001-07-31 | 2005-05-03 | Posco | Vaccine composition containing a promoter peptide |
| US6945952B2 (en) | 2002-06-25 | 2005-09-20 | Theraject, Inc. | Solid solution perforator for drug delivery and other applications |
| US8062573B2 (en) | 2002-09-16 | 2011-11-22 | Theraject, Inc. | Solid micro-perforators and methods of use |
| US7314613B2 (en) | 2002-11-18 | 2008-01-01 | Maxygen, Inc. | Interferon-alpha polypeptides and conjugates |
| US20050137525A1 (en) | 2003-06-04 | 2005-06-23 | Georgia Tech Research Corporation | Drilling microneedle device |
| US9744227B2 (en) | 2004-06-02 | 2017-08-29 | Universal Stabilization Technologies, Inc. | Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals and methods for formulation thereof |
| GB0416694D0 (en) * | 2004-07-27 | 2004-09-01 | Univ Strathclyde | Process for preparing microcrystals |
| US20080269666A1 (en) | 2005-05-25 | 2008-10-30 | Georgia Tech Research Corporation | Microneedles and Methods for Microinfusion |
| WO2006138719A2 (en) | 2005-06-17 | 2006-12-28 | Georgia Tech Research Corporation | Coated microstructures and method of manufacture thereof |
| CN101312742B (zh) | 2005-09-16 | 2012-07-25 | 梅瑞尔有限公司 | 用于冷冻干燥的疫苗的稳定剂 |
| US20090182306A1 (en) | 2006-07-21 | 2009-07-16 | Georgia Tech Research Corporation | Microneedle Devices and Methods of Drug Delivery or Fluid Withdrawal |
| WO2008111532A1 (ja) * | 2007-03-09 | 2008-09-18 | Otsuka Pharmaceutical Co., Ltd. | インフルエンザワクチン含有凍結乾燥製剤、及びその製造方法 |
| US8911749B2 (en) | 2007-04-16 | 2014-12-16 | Corium International, Inc. | Vaccine delivery via microneedle arrays |
| GB0725018D0 (en) | 2007-12-21 | 2008-01-30 | Univ Cardiff | Monitoring system for microneedle delivery |
| CA2716546A1 (en) | 2008-02-25 | 2009-09-03 | Novavax, Inc. | Sugar glassified virus like particles (vlps) |
| MX2010008799A (es) * | 2008-03-05 | 2010-09-07 | Sanofi Pasteur | Proceso para estabilizar una composicion de vacuna que contiene adyuvante. |
| TWI489994B (zh) | 2008-03-17 | 2015-07-01 | Baxter Healthcare Sa | 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法 |
| CA2729404C (en) * | 2008-06-30 | 2016-09-27 | Hisamitsu Pharmaceutical Co., Inc. | Microneedle device and method for enhancing the efficacy of influenza vaccine using microneedle device |
| ES2625260T5 (es) * | 2009-03-26 | 2020-07-29 | Pulmatrix Operating Co Inc | Formulaciones de polvo seco y métodos para el tratamiento de enfermedades pulmonares |
| EP2459716B1 (en) | 2009-07-31 | 2016-08-17 | Paxvax, Inc. | Adenoviral-based vectors |
| US20110243988A1 (en) | 2009-10-01 | 2011-10-06 | Aridis Pharmaceuticals | Methods and Compositions for Stabilization of a Virus Vaccine |
| US8557253B2 (en) * | 2009-10-07 | 2013-10-15 | Sanofi Pasteur Sa | Stabilizing excipient for inactivated whole virus vaccine |
| CN102892424B (zh) | 2010-03-31 | 2015-04-01 | 稳定性科技有限公司 | 病毒颗粒的稳定 |
| CA2993242C (en) | 2010-04-15 | 2020-12-15 | Shin Nippon Biomedical Laboratories, Ltd. | Methods and compositions for intranasal delivery |
| GB201007207D0 (en) | 2010-04-29 | 2010-06-16 | Univ Cork | Method |
| CN102939104A (zh) | 2010-06-01 | 2013-02-20 | 诺华有限公司 | 用冻干浓缩疫苗抗原 |
| WO2011156641A2 (en) | 2010-06-09 | 2011-12-15 | Kaspar Roger L | Microneedle arrays for active agent delivery |
| JP5808102B2 (ja) * | 2010-07-22 | 2015-11-10 | コスメディ製薬株式会社 | 抗原を含有する経皮免疫製剤およびその製造方法 |
| WO2012023044A1 (en) | 2010-08-20 | 2012-02-23 | Novartis Ag | Soluble needle arrays for delivery of influenza vaccines |
| JP5558311B2 (ja) | 2010-10-27 | 2014-07-23 | 株式会社バイオセレンタック | ワクチン抗原表皮デリバリー用溶解性３層マイクロニードル・アレイ・パッチ |
| US9089677B2 (en) | 2011-01-25 | 2015-07-28 | The Regents Of The University Of California | Transcutaneous multimodal delivery system (TMDS) |
| BR112013027057A2 (pt) | 2011-04-21 | 2020-08-11 | Trustees Of Tufts College | composições e métodos para a estabilização de agentes ativos |
| CN103781491A (zh) | 2011-05-17 | 2014-05-07 | 索利吉尼克斯公司 | 热稳定性疫苗组合物及其制备方法 |
| US20130096532A1 (en) | 2011-10-17 | 2013-04-18 | Rutgers, The State University Of New Jersey | Polymer-Based Micro-Needle Array Designs, Fabrication Processes, and Methods of Use Thereof for Drug Delivery |
| CA2857502C (en) * | 2011-11-30 | 2019-08-13 | 3M Innovative Properties Company | Microneedle device including a peptide therapeutic agent and an amino acid and methods of making and using the same |
| WO2013152092A1 (en) | 2012-04-03 | 2013-10-10 | Theraject, Inc. | Soluble microneedle arrays for buccal delivery of vaccines |
| WO2014004462A1 (en) | 2012-06-25 | 2014-01-03 | Flugen, Inc. | Multiple drug delivery device |
| CA2906945A1 (en) | 2013-03-15 | 2014-09-18 | Incube Labs, Llc | Multi-stage biodegradable drug delivery platform |
| NZ731659A (en) | 2014-11-03 | 2018-10-26 | Merial Inc | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
-
2014
- 2014-09-03 WO PCT/US2014/053902 patent/WO2015034924A1/en not_active Ceased
- 2014-09-03 EP EP14843082.0A patent/EP3041504B1/en active Active
- 2014-09-03 RU RU2016111354A patent/RU2720808C2/ru active
- 2014-09-03 CA CA2923010A patent/CA2923010C/en active Active
- 2014-09-03 CN CN201480052624.6A patent/CN105579059B/zh active Active
- 2014-09-03 JP JP2016540347A patent/JP6611720B2/ja active Active
- 2014-09-03 ES ES14843082T patent/ES2897659T3/es active Active
- 2014-09-03 US US14/916,417 patent/US10736840B2/en active Active
-
2019
- 2019-04-23 JP JP2019082137A patent/JP7358068B2/ja active Active